In Conversation: Measuring Aspects Of Health In Heart Failure Research


Dr. Bill Byrom, Principal of eCOA Science at Signant Health, recently had the privilege of engaging in a dialogue with Professor Marianna Fontana, a distinguished figure in Cardiology and an Honorary Consultant Cardiologist at the National Amyloidosis Centre, University College London (UCL). Professor Fontana also serves as a valued member of the Signant Health Scientific Advisory Board.

Their conversation centered around the present and future opportunities for enhancing the measurement of health-related aspects crucial for augmenting the effectiveness of clinical outcome assessments (COAs) in heart failure clinical trials. Dive into their insightful discussion to gain deeper insights into the utilization of measures such as 6MWT, actigraphy, and sensor-derived data in clinical trial contexts.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader